Hochster HS, Catalano P, Weitz M, Mitchell EP, et al. Combining anti-VEGFR and anti-EGFR antibodies: Randomized phase II study of irinotecan and cetuximab with/without ramucirumab in second-line colorectal cancer:(ECOG-ACRIN E7208). J Natl Cancer Inst 2024 May 22:djae114. doi: 10.1093.
PMID: 38775718